Literature DB >> 12653845

Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians.

A Kassu1, A Tsegaye, D Wolday, B Petros, M Aklilu, E J Sanders, A L Fontanet, D Van Baarle, D Hamann, T F Rinke De Wit.   

Abstract

Intestinal parasitic infections have been suggested to cause persistent immune activation leading to an unbalanced immune state. Such a state has been proposed to be a major factor in the pathogenesis of AIDS in an African context. The present study investigated the effect of incidental parasitic infection and treatment on the profile of T cell differentiation and activation markers on CD4+ and CD8+ T cells from HIV-1 infected and uninfected adult Ethiopians. Cryopreserved PBMCs from 64 subjects (41 HIV-negative and 23 HIV-positive) with follow-up visits at 6-monthly intervals were used to compare the effect of incidental intestinal parasites and their treatment upon T cell subset profiles and activation status. The samples were stained with antibodies to various T cell differentiation and activation markers allowing naive, memory, effector, memory/effector, activated and resting CD4+ and CD8+ T cell subsets to be quantified by triple-colour FACScan. Incidental intestinal parasitic infections resulted in a significant increase in memory CD4+ T cell numbers both in HIV-negative and HIV-positive subjects (P < 0.05). There was also a significant increase in the percentage of CD8+ HLA-DR+ T cells (P < 0.05) in HIV-positive subjects co-infected with parasites. In HIV-negative subjects, a significant decline in activated cells and a significant increase in resting CD8+ T cells (P < 0.05) was observed after treatment for parasites. These data suggest that intestinal parasitic infections could result in the alteration of T cell subset counts and also in the up-regulation of T cell activation markers in peripheral blood. Treatment of parasitic infections showed a tendency to reduce the activation suggesting that, together with other community based intervention strategies, such treatment could be used to down-regulate immune activation and hence protect the host from being easily attacked by HIV.

Entities:  

Mesh:

Year:  2003        PMID: 12653845      PMCID: PMC1808681          DOI: 10.1046/j.1365-2249.2003.02106.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Diagnosis of strongyloidiasis: importance of Baermann's method.

Authors:  J P LIMA; P G DELGADO
Journal:  Am J Dig Dis       Date:  1961-09

2.  Higher proportion of CD8+ T cells in the blood in healthy adults from Ethiopia and Bangladesh compared with Sweden.

Authors:  S Worku; B Christensson; A Björkman; D Islam
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

3.  Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.

Authors:  Janis V Giorgi; Robert H Lyles; Jose L Matud; Traci E Yamashita; John W Mellors; Lance E Hultin; Beth D Jamieson; Joseph B Margolick; Charles R Rinaldo; John P Phair; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-01       Impact factor: 3.731

Review 4.  Natural history and spectrum of disease in adults with HIV/AIDS in Africa.

Authors:  A D Grant; G Djomand; K M De Cock
Journal:  AIDS       Date:  1997       Impact factor: 4.177

5.  Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia.

Authors:  T Sahlu; E Kassa; T Agonafer; A Tsegaye; T Rinke de Wit; H Gebremariam; R Doorly; I Spijkerman; H Yeneneh; R A Coutinho; A L Fontanet
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

6.  Release of interleukin 2 and gamma interferon by peripheral mononuclear cells in human Schistosoma mansoni infection normalizes after chemotherapy.

Authors:  K Zwingenberger; E Irschick; J G Siqueira Vergetti; A R Correia Dacal; R Janssen-Rosseck; U Bienzle; C Huber; H Feldmeier
Journal:  Scand J Immunol       Date:  1989-10       Impact factor: 3.487

Review 7.  How does HIV cause AIDS?

Authors:  R A Weiss
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

8.  Regulation of CD27 expression on subsets of mature T-lymphocytes.

Authors:  R Q Hintzen; R de Jong; S M Lens; M Brouwer; P Baars; R A van Lier
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

Review 9.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  24 in total

Review 1.  Inflammation and HIV Transmission in Sub-Saharan Africa.

Authors:  Rupert Kaul; Jessica Prodger; Vineet Joag; Brett Shannon; Sergey Yegorov; Ronald Galiwango; Lyle McKinnon
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

2.  HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.

Authors:  Michael A Eller; Marc S Opollo; Michelle Liu; Andrew D Redd; Leigh Anne Eller; Cissy Kityo; Joshua Kayiwa; Oliver Laeyendecker; Maria J Wawer; Mark Milazzo; Noah Kiwanuka; Ronald H Gray; David Serwadda; Nelson K Sewankambo; Thomas C Quinn; Nelson L Michael; Fred Wabwire-Mangen; Johan K Sandberg; Merlin L Robb
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

3.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

4.  Serum IgE levels of tuberculosis patients in a tropical setup with high prevalence of HIV and intestinal parasitoses.

Authors:  A Kassu; A Mohammad; Y Fujimaki; F Moges; D Elias; F Mekonnen; G Mengistu; M Yamato; Y Wondmikun; F Ota
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 5.  Deworming helminth co-infected individuals for delaying HIV disease progression.

Authors:  Judd L Walson; Bradley R Herrin; Grace John-Stewart
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

6.  The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections.

Authors:  S Perry; A H Chang; L Sanchez; S Yang; T D Haggerty; J Parsonnet
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 2.451

Review 7.  Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings.

Authors:  J L Walson; G John-Stewart
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

8.  Prevalence of Opportunistic Intestinal Parasitic Infections Among HIV/AIDS Patients Before and After Commencement of Antiretroviral Treatment at Felege Hiwot Referral Hospital: A Follow-up Study.

Authors:  Tigest Getachew; Tadesse Hailu; Megbaru Alemu
Journal:  HIV AIDS (Auckl)       Date:  2021-07-16

Review 9.  Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.

Authors:  Dawit Wolday; Francis M Ndungu; Gloria P Gómez-Pérez; Tobias F Rinke de Wit
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 10.  Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature.

Authors:  Judd L Walson; Grace John-Stewart
Journal:  PLoS Negl Trop Dis       Date:  2007-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.